Sometimes, people with mild thalassemia may be told to supplement with iron. Iron supplements are only appropriate for certain types of thalassemia, though, and can be dangerous for people with more ...

—Researchers recently examined how different iron chelation medications—deferoxamine, deferiprone, and deferasirox—impacted iron stores and long-term health in patients with transfusion-dependent ...

DEAR DR. ROACH: I am Greek and have thalassemia minor. In general, my red blood cells are much smaller than typical ones, and my iron content is significantly low. Every time I see a different doctor ...

Beta thalassemia is a blood condition that causes low levels of functional red blood cells, which may sometimes cause mild to severe anemia. Beta thalassemia results from mutations in the HBB gene, ...

If you or your child gets a diagnosis of the blood disorder beta thalassemia, it's important to find out which type it is. The kind of disease you have affects the symptoms you can expect and the ...

If you have beta thalassemia and you're pregnant -- or plan to start a family -- there are steps you should take to protect your health and you baby's health. With the right care, you should be able ...

beta-thalassemia minor, which causes few or no symptoms beta-thalassemia major, which causes serious symptoms and may require blood transfusions beta-thalassemia intermedia, which causes symptoms ...

Beta-thalassemia is an inherited blood disorder that results in chronic anemia. A major complication of the condition is iron overload, which has been linked to low levels of the protein hepcidin. New ...

Orphan drug designation incentives have helped boost enthusiasm for researching and developing drugs for beta thalassemia, a new review concludes. The review encompassed all beta-thalassemia drugs ...

Synthetic peptides called minihepcidins may potentially treat two serious genetic blood diseases in children and adults, new research suggests. Although those diseases, beta-thalassemia and ...

Investigators used MRI to evaluate brain perfusion in patients with transfusion-dependent (n=54) and non–transfusion-dependent (n=23) β-thalassemia versus 56 controls. They found that relative ...